- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 126,410 | 05.07.24 22:00:00 | +0,560 | +0,44% | 125,830 | 126,540 | 127,690 | 125,850 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 84,330 | 05.07.24 21:58:47 | +1,630 | +1,97% | 84,360 | 84,530 | 84,900 | 82,700 |
